ABL Bio Dividend
Dividend criteria checks 0/6
ABL Bio does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-0.09%
Buyback Yield
| Total Shareholder Yield | -0.09% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend updates
No updates
Recent updates
Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?
May 29
Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?
Feb 26We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth
Mar 31Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?
Jan 20
Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth
Dec 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A298380's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A298380's dividend payments have been increasing.
Dividend Yield vs Market
| ABL Bio Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A298380) | n/a |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.7% |
| Industry Average (Biotechs) | 0.5% |
| Analyst forecast (A298380) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate A298380's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A298380's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A298380's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A298380 has not reported any payouts.